COVID-19 and the liver: an adverse outcome pathway perspective

Liver damage is observed in up to half of hospitalized COVID-19 patients and can result either from actions of SARS-CoV-2 as such or from pharmacological treatment. The present paper introduces an adverse outcome pathway construct that mechanistically describes the pathways induced by SARS-CoV-2 lea...

Descripción completa

Detalles Bibliográficos
Autor principal: Vinken, Mathieu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986318/
https://www.ncbi.nlm.nih.gov/pubmed/33771662
http://dx.doi.org/10.1016/j.tox.2021.152765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986318/
https://www.ncbi.nlm.nih.gov/pubmed/33771662
http://dx.doi.org/10.1016/j.tox.2021.152765

Ejemplares similares